triphenyltetrazolium has been researched along with ginsenosides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, DF; Li, M; Tan, HM; Wang, Z; Wu, WK | 1 |
1 other study(ies) available for triphenyltetrazolium and ginsenosides
| Article | Year |
|---|---|
Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction.
Topics: Androstadienes; Animals; Blood Pressure; Blotting, Western; Creatine Kinase; Creatine Kinase, MB Form; Dimethyl Sulfoxide; Drug Administration Schedule; Drug Therapy, Combination; Ginsenosides; Heart Rate; Injections, Intravenous; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Molecular Structure; Myocardial Infarction; Myocardial Reperfusion Injury; Panax; Pharmaceutical Vehicles; Phosphatidylinositol 3-Kinases; Phosphorylation; Placebos; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetrazolium Salts; Troponin T; Wortmannin | 2008 |